UNSPSC 51373406: Ammonium chloride/chlorpheniramine/codeine/phenylephrine/potassium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373406 Ammonium chloride/chlorpheniramine/codeine/phenylephrine/potassium is a Commodity code that covers pharmaceutical compounds and specialty medications used in clinical settings. Recent state and local solicitations under this code show purchasing activity focused on parenteral (intravenous and injectable) products, opioid antagonists, and drug-management systems rather than the specific chemical compound named in the code title. The Washington State Department of Corrections and Seminole County, Florida represent the issuing bodies active under this code in the recent record. Scope of work includes supplying parenteral nutrition solutions (TPN and PPN), intravenous solutions, controlled substances for inpatient care, naloxone (opioid reversal medication), and drug deactivation systems. The Washington DOC solicitation emphasizes rapid fulfillment—parenteral nutrition bags delivered within 24 hours of order and other parenteral products within 8 hours—and requires vendors to demonstrate experience in IV solution preparation, patient monitoring, and nutritional formulation adjustment. Contractors must maintain commercial general liability, professional liability, business automobile liability, and cyber liability insurance, with fixed pricing locked for multi-year terms.

The code sees recent activity in Washington and Florida. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, due October 7, 2026, for parenteral products, services, and equipment supporting eight correctional facilities across three regions; DOC anticipates awarding up to three contractors per region under an initial term running November 26, 2026 through June 30, 2030. The solicitation includes set-aside goals for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with required subcontractor inclusion plans. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026 (with a due date of July 26, 2023, indicating a data inconsistency in the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the contract included a two-year initial term with one-year renewal option. Both opportunities require E-Verify compliance and drug-free workplace certification, and both involve healthcare or public-health service delivery.